EQUILLIUM, INC. (EQ) Debt / Equity
- 2023-03-31: Debt/Equity Ratio 0.26.
- 2022-12-31: Debt/Equity Ratio 0.28.
- 2022-09-30: Debt/Equity Ratio 0.37.
- 2022-06-30: Debt/Equity Ratio 0.26.
Complete source-backed debt/equity ratio history.
- Available history
- 2020-09-30 to 2023-03-31
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2023-03-31 | 0.26 |
| 2022-12-31 | 0.28 |
| 2022-09-30 | 0.37 |
| 2022-06-30 | 0.26 |
| 2022-03-31 | 0.19 |
| 2021-12-31 | 0.15 |
| 2021-09-30 | 0.13 |
| 2021-06-30 | 0.12 |
| 2021-03-31 | 0.11 |
| 2020-12-31 | 0.14 |
| 2020-09-30 | 0.13 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2022-12-31 | 0.28 |
| 2021-12-31 | 0.15 |
| 2020-12-31 | 0.14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |